Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Biosynthesized of reduced graphene oxide nanosheets and its loading with paclitaxel for their anti cancer effect for treatment of lung cancer.

Lin S, Ruan J, Wang S.

J Photochem Photobiol B. 2019 Feb;191:13-17. doi: 10.1016/j.jphotobiol.2018.11.015. Epub 2018 Nov 22.

PMID:
30557788
2.

Targeting Thioredoxin System with an Organosulfur Compound, Diallyl Trisulfide (DATS), Attenuates Progression and Metastasis of Triple-Negative Breast Cancer (TNBC).

Liu Y, Zhao Y, Wei Z, Tao L, Sheng X, Wang S, Chen J, Ruan J, Liu Z, Cao Y, Shan Y, Wang A, Chen W, Lu Y.

Cell Physiol Biochem. 2018;50(5):1945-1963. doi: 10.1159/000494874. Epub 2018 Nov 5.

3.

Impact of CYP2A6 gene polymorphism on the pharmacokinetics of dexmedetomidine for premedication.

Wang L, Wang S, Qi J, Yu R, Zhuang J, Zhuang B, Lou Y, Ruan J, Ye H, Lin F.

Expert Rev Clin Pharmacol. 2018 Sep;11(9):917-922. doi: 10.1080/17512433.2018.1510312. Epub 2018 Aug 24.

PMID:
30092666
4.

Molecular Cancer Imaging in the Second Near-Infrared Window Using a Renal-Excreted NIR-II Fluorophore-Peptide Probe.

Wang W, Ma Z, Zhu S, Wan H, Yue J, Ma H, Ma R, Yang Q, Wang Z, Li Q, Qian Y, Yue C, Wang Y, Fan L, Zhong Y, Zhou Y, Gao H, Ruan J, Hu Z, Liang Y, Dai H.

Adv Mater. 2018 May;30(22):e1800106. doi: 10.1002/adma.201800106. Epub 2018 Apr 23.

5.

Pharmacokinetics of multiple doses of teicoplanin in Chinese elderly critical patients.

Wang S, Lin F, Ruan J, Ye H, Wang L.

Expert Rev Clin Pharmacol. 2018 May;11(5):537-541. doi: 10.1080/17512433.2018.1449107. Epub 2018 Mar 13.

PMID:
29506414
6.

Antimetastatic Therapies of the Polysulfide Diallyl Trisulfide against Triple-Negative Breast Cancer (TNBC) via Suppressing MMP2/9 by Blocking NF-κB and ERK/MAPK Signaling Pathways.

Liu Y, Zhu P, Wang Y, Wei Z, Tao L, Zhu Z, Sheng X, Wang S, Ruan J, Liu Z, Cao Y, Shan Y, Sun L, Wang A, Chen W, Lu Y.

PLoS One. 2015 Apr 30;10(4):e0123781. doi: 10.1371/journal.pone.0123781. eCollection 2015.

7.

Chemomodulatory efficacy of lycopene on antioxidant enzymes and carcinogen-induced cutaneum carcinoma in mice.

Shen C, Wang S, Shan Y, Liu Z, Fan F, Tao L, Liu Y, Zhou L, Pei C, Wu H, Tian C, Ruan J, Chen W, Wang A, Zheng S, Lu Y.

Food Funct. 2014 Jul 25;5(7):1422-31. doi: 10.1039/c4fo00035h.

PMID:
24781038
8.

Concerted suppression of STAT3 and GSK3β is involved in growth inhibition of non-small cell lung cancer by Xanthatin.

Tao L, Fan F, Liu Y, Li W, Zhang L, Ruan J, Shen C, Sheng X, Zhu Z, Wang A, Chen W, Huang S, Lu Y.

PLoS One. 2013 Nov 28;8(11):e81945. doi: 10.1371/journal.pone.0081945. eCollection 2013.

9.

Inhibition of hypoxia-induced epithelial mesenchymal transition by luteolin in non-small cell lung cancer cells.

Ruan J, Zhang L, Yan L, Liu Y, Yue Z, Chen L, Wang AY, Chen W, Zheng S, Wang S, Lu Y.

Mol Med Rep. 2012 Jul;6(1):232-8. doi: 10.3892/mmr.2012.884. Epub 2012 Apr 23.

PMID:
22552526
10.

Xanthatin induces G2/M cell cycle arrest and apoptosis in human gastric carcinoma MKN-45 cells.

Zhang L, Tao L, Ruan J, Li W, Wu Y, Yan L, Zhang F, Fan F, Zheng S, Wang A, Lu Y.

Planta Med. 2012 Jun;78(9):890-5. doi: 10.1055/s-0031-1298481. Epub 2012 Apr 24.

PMID:
22532019
11.

Xanthatin induces cell cycle arrest at G2/M checkpoint and apoptosis via disrupting NF-κB pathway in A549 non-small-cell lung cancer cells.

Zhang L, Ruan J, Yan L, Li W, Wu Y, Tao L, Zhang F, Zheng S, Wang A, Lu Y.

Molecules. 2012 Mar 26;17(4):3736-50. doi: 10.3390/molecules17043736.

Supplemental Content

Loading ...
Support Center